LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 63.99 | 84.90 | 1314 | 8212 | 0.1600 | 0.5149 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 63.99 | 84.90 | 1095 | 8212 | 0.1333 | 0.4736 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 63.99 | 84.90 | 1123 | 8212 | 0.1368 | 0.4792 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 65.70 | 84.90 | 1322 | 8484 | 0.1558 | 0.5118 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 65.70 | 84.90 | 1346 | 8484 | 0.1587 | 0.5159 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 65.70 | 84.90 | 1086 | 8484 | 0.1280 | 0.4677 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 65.70 | 84.90 | 1110 | 8484 | 0.1308 | 0.4725 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 67.41 | 84.90 | 1341 | 8766 | 0.1530 | 0.5106 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 67.41 | 84.90 | 1360 | 8766 | 0.1551 | 0.5138 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 67.41 | 84.90 | 1096 | 8766 | 0.1250 | 0.4657 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 67.41 | 84.90 | 1121 | 8766 | 0.1279 | 0.4707 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 69.11 | 84.90 | 1360 | 8988 | 0.1513 | 0.5104 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 69.11 | 84.90 | 1384 | 8988 | 0.1540 | 0.5144 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 69.11 | 84.90 | 1100 | 8988 | 0.1224 | 0.4635 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 69.11 | 84.90 | 1127 | 8988 | 0.1254 | 0.4688 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 70.81 | 84.90 | 1363 | 9132 | 0.1493 | 0.5088 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 70.81 | 84.90 | 1387 | 9132 | 0.1519 | 0.5127 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 70.81 | 84.90 | 1108 | 9132 | 0.1213 | 0.4632 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 70.81 | 84.90 | 1135 | 9132 | 0.1243 | 0.4684 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 72.52 | 84.90 | 1379 | 9214 | 0.1497 | 0.5102 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 72.52 | 84.90 | 1403 | 9214 | 0.1523 | 0.5141 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 72.52 | 84.90 | 1104 | 9214 | 0.1198 | 0.4614 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 72.52 | 84.90 | 1129 | 9214 | 0.1225 | 0.4662 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 74.22 | 84.90 | 1399 | 9343 | 0.1497 | 0.5116 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 74.22 | 84.90 | 1429 | 9343 | 0.1529 | 0.5163 | MN20160318_Q02 | C04 |